For this reason, the EGFR is a target molecule for inhibiting cancer cell growth, and various EGFR tyrosine kinase inhibitors (EGFR-TKIs) have been developed for proactive use against refractory cancers [3,4,5]. The gene discussed is EGFR; the disease is cancer.